雄激素使小鼠对糖皮质激素诱导的胰岛素抵抗和脂肪堆积更敏感
该研究在CD1小鼠中给予4周超生理剂量皮质酮,发现慢性糖皮质激素仅引起雄性小鼠胰岛素抵抗、空腹高胰岛素血症、脂肪增加和血脂异常。去势改善雄性基线胰岛素敏感性并减轻皮质酮诱导的胰岛素抵抗,但不阻止脂肪堆积;双氢睾酮可加重白色脂肪堆积和棕色脂肪「白化」。
要点
- 慢性皮质酮代谢损害存在性别差异,雄性小鼠更易发生胰岛素抵抗和脂肪堆积。
- 去势改善雄性基线胰岛素敏感性并减轻皮质酮诱导的胰岛素抵抗,但不阻止脂肪堆积。
- 雄激素是皮质酮诱导棕色脂肪脂质堆积和白色脂肪肥大的必要条件。
核心结论
- 在小鼠中,雄激素增强慢性糖皮质激素治疗后的胰岛素抵抗、脂肪堆积和棕色脂肪「白化」。
研究设计与样本
- 雄性及雌性CD1小鼠接受4周超生理剂量(约250 μg/天)皮质酮或等体积溶媒(不含皮质酮的饮用水)处理。
- 另设去势或卵巢切除组,部分联合双氢睾酮替代,以评估性激素对皮质酮代谢效应的影响。
主要发现
- 慢性皮质酮处理导致雄性而非雌性小鼠出现胰岛素抵抗、空腹高胰岛素血症、脂肪增加和血脂异常。
- 雄性去势改善基线胰岛素敏感性并减轻皮质酮诱导的胰岛素抵抗,但未阻止脂肪堆积。
- 在雄激素缺乏小鼠(去势雄性、完整及卵巢切除雌性)中,双氢睾酮使皮质酮处理导致胰岛素抵抗和血脂异常。
- 雄激素为皮质酮诱导棕色脂肪细胞内脂质堆积(「白化」)所必需,双氢睾酮通过增加脂肪细胞肥大加重皮质酮诱导的白色脂肪堆积。
- 雄激素抑制循环脂联素浓度,但皮质酮诱导的胰岛素抵抗不涉及脂联素的额外抑制。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS/HYPOTHESIS: Chronic glucocorticoid therapy causes insulin resistance, dyslipidaemia, abnormal fat accumulation, loss of muscle mass and osteoporosis. Here we describe a hitherto unknown sexual dimorphism in the metabolic response to chronic glucocorticoid exposure in mice. This led us to investigate whether glucocorticoid-induced insulin resistance and obesity were dependent on sex hormones. METHODS: Male and female CD1 mice were treated for 4 weeks with supraphysiological doses (~250 μg/day) of corticosterone, the main glucocorticoid in rodents, or equivalent volume of vehicle (drinking water without corticosterone). To investigate the effects of sex hormones, a separate group of mice were either orchidectomised or ovariectomised prior to corticosterone treatment, with or without dihydrotestosterone replacement. Body composition was determined before and after corticosterone treatment, and insulin tolerance was assessed after 7 and 28 days of treatment. Adipocyte morphology was assessed in white and brown adipose tissues by immunohistochemistry, and fasting serum concentrations of NEFA, triacylglycerols, total cholesterol and free glycerol were measured using colorimetric assays. Obesity- and diabetes-related hormones were measured using multiplex assays, and RNA and protein expression in adipose tissues were measured by RT-PCR and immunoblotting, respectively. RESULTS: Chronic corticosterone treatment led to insulin resistance, fasting hyperinsulinaemia, increased adiposity and dyslipidaemia in male, but not female mice. In males, orchidectomy improved baseline insulin sensitivity and attenuated corticosterone-induced insulin resistance, but did not prevent fat accumulation. In androgen-deficient mice (orchidectomised males, and intact and ovariectomised females) treated with dihydrotestosterone, corticosterone treatment led to insulin resistance and dyslipidaemia. In brown adipose tissue, androgens were required for corticosterone-induced intracellular lipid accumulation ('whitening'), and dihydrotestosterone specifically exacerbated corticosterone-induced accumulation of white adipose tissue by increasing adipocyte hypertrophy. Androgens also suppressed circulating adiponectin concentrations, but corticosterone-induced insulin resistance did not involve additional suppression of adiponectin levels. In white adipose tissue, androgens were required for induction of the glucocorticoid target gene Gilz (also known as Tsc22d3) by corticosterone. CONCLUSIONS/INTERPRETATION: In mice, androgens potentiate the development of insulin resistance, fat accumulation and brown adipose tissue whitening following chronic glucocorticoid treatment.
引用
- Gasparini SJ, Swarbrick MM, Kim S, et al. Androgens sensitise mice to glucocorticoid-induced insulin resistance and fat accumulation. Diabetologia. 2019. PMID: 31098671. doi:10.1007/s00125-019-4887-0
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。